To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
Management of biologic DMARDs in patients undergoing orthopaedic surgery is variable; flare avoidance is a priority.
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2021
|